G-Technology

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Wednesday, August 17, 2022
Seraph, HIV, Identity theft, Lists of action films, Pomerantz, GLOBE, Technology, Hindenburg Research, Securities Exchange Act of 1934, Cancer, SRI, SEC Rule 10b-5, LLC, Defendant, Company, Coronavirus, LLP, Court, U.S. Department of Justice Office of Legislative Affairs, Lists of schools in England, Ext, G-Technology, Office of Inspector General, U.S. Department of Health and Human Services, Complaint, Fraud, Hindenburg, NASDAQ, District court, News, Science, For Hire, Hepatitis B virus, China Biologic Products, Justice, Central District, Person, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

TGTX, YQ & ENOB Class Actions Deadlines: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm, Reminds Investors to Contact the Firm and Actively Participate

Retrieved on: 
Thursday, August 11, 2022
FDA, Survival, NDA, Academy, GLOBE, Prospectus, SRI, LLC, Defendant, Court, U2, Lists of schools in England, Company, G-Technology, Complaint, Register, Fraud, Education, NASDAQ, Registration statement, YQ, IPO, Overalls, Pharmaceutical industry, Public relations, Ublituximab, Umbralisib

NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.

Key Points: 
  • NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.
  • You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at212-697-6484.
  • If you suffered a loss, you can request that the Court appoint you as lead plaintiff.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian, Weber, and Coinbase and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, August 11, 2022
Seraph, HIV, Bankruptcy, Disclosure, Risk, NYSE, Â, GLOBE, Georgetown University Law Center, Technology, Ecosystem, Hindenburg Research, Coinbase, SEC, Weber, WEBR, Bloomberg, Cancer, SRI, LLC, Defendant, Texas Law Review, Coronavirus, U.S. Department of Justice Office of Legislative Affairs, U.S. Department of Defense Strategy for Operating in Cyberspace, Company, Lists of schools in England, G-Technology, Credit risk, Register, Fraud, Hindenburg, NASDAQ, News, Science, For Hire, Hepatitis B virus, Registration statement, China Biologic Products, IPO, Justice, Complaint, Identity theft, Private investigator, Renewable energy, Pharmaceutical industry, Audit, Security (finance), Cryptocurrency, P.C, Enochian

On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.

Key Points: 
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, Enochians stock price fell $2.17 per share, or 36.97%, to close at $3.70 per share on May 25, 2022.
  • For more information on the Coinbase class action go to: https://bespc.com/cases/COIN
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Wednesday, August 10, 2022
Seraph, HIV, Identity theft, Lists of action films, Pomerantz, GLOBE, Technology, Hindenburg Research, Securities Exchange Act of 1934, Cancer, SRI, SEC Rule 10b-5, LLC, Defendant, Company, Coronavirus, LLP, Court, U.S. Department of Justice Office of Legislative Affairs, Lists of schools in England, Ext, G-Technology, Office of Inspector General, U.S. Department of Health and Human Services, Complaint, Fraud, Hindenburg, NASDAQ, District court, News, Science, For Hire, Hepatitis B virus, China Biologic Products, Justice, Central District, Person, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

INVESTOR DEADLINE: Investors in Enochian Biosciences Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – ENOB

Retrieved on: 
Saturday, August 6, 2022
Class Action Lawsuit, Professional Services, Legal, Seraph, Central District, FBI, Risk, Private Securities Litigation Reform Act, Technology, Enron, Hindenburg Research, Securities Exchange Act of 1934, Cancer, HBV, SRI, LLC, Lawyer, History, Company, CASE, Coronavirus, Robbins Geller Rudman & Dowd LLP, U.S. Department of Justice Office of Legislative Affairs, Lists of schools in England, Office of Inspector General, U.S. Department of Health and Human Services, SEC, G-Technology, List of life sciences, Fraud, Hindenburg, NASDAQ, News, Science, For Hire, HIV, China Biologic Products, The Wall Street Journal, Justice, Identity theft, Complaint, Tobacco, Pharmaceutical industry, Enochian

The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.

Key Points: 
  • The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.
  • Enochian Biosciences and its top management have credited Serhat Gumrukcu (Gumrukcu), Enochian Biosciences co-founder, as the inventor of the technology and science behind Enochian Biosciences product pipeline.
  • A lead plaintiff acts on behalf of all other class members in directing the Enochian Biosciences class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Enochian Biosciences class action lawsuit.

Bronstein, Gewirtz & Grossman, LLC Notifies Enochian Biosciences Inc. (ENOB) Investors of Class Action and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, August 5, 2022
Risk, GLOBE, SRI, LLC, Defendant, Court, Review, Lists of schools in England, Company, G-Technology, Complaint, Fraud, NASDAQ, Person, Private investigator, Enochian

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/enob .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/enob .
  • The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

Bronstein, Gewirtz & Grossman, LLC Notifies Enochian Biosciences Inc. (ENOB) Investors of Class Action and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, August 3, 2022
Class Action Lawsuit, Professional Services, Legal, SRI, Lists of schools in England, Defendant, Company, Review, G-Technology, Fraud, Complaint, Court, Person, LLC, Risk, NASDAQ, Private investigator, Enochian

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/enob .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/enob .
  • The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

INVESTOR NOTICE: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENOB

Retrieved on: 
Tuesday, August 2, 2022
Class Action Lawsuit, Professional Services, Legal, Seraph, Private Securities Litigation Reform Act, Identity theft, Company, The Wall Street Journal, Hindenburg, For Hire, History, Central District, FBI, China Biologic Products, Securities Exchange Act of 1934, Risk, U.S. Department of Justice Office of Legislative Affairs, List of life sciences, NASDAQ, Fraud, Cancer, News, CASE, Robbins Geller Rudman & Dowd LLP, Office of Inspector General, U.S. Department of Health and Human Services, Technology, Science, G-Technology, SEC, Lawyer, Lists of schools in England, Justice, HBV, Hindenburg Research, Complaint, LLC, SRI, HIV, Coronavirus, Enron, Tobacco, Pharmaceutical industry, Enochian

The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.

Key Points: 
  • The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.
  • Enochian Biosciences and its top management have credited Serhat Gumrukcu (Gumrukcu), Enochian Biosciences co-founder, as the inventor of the technology and science behind Enochian Biosciences product pipeline.
  • A lead plaintiff acts on behalf of all other class members in directing the Enochian Biosciences class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Enochian Biosciences class action lawsuit.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Monday, August 1, 2022
Seraph, LLP, Identity theft, Company, GLOBE, Court, For Hire, Hindenburg, Central District, Lists of action films, Hepatitis B virus, Person, China Biologic Products, Securities Exchange Act of 1934, HIV, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, Fraud, Cancer, News, SEC Rule 10b-5, Ext, Office of Inspector General, U.S. Department of Health and Human Services, Technology, Science, Defendant, G-Technology, Lists of schools in England, Complaint, District court, Justice, Hindenburg Research, LLC, SRI, Pomerantz, Coronavirus, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian and Weber and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, August 1, 2022
Seraph, Register, Identity theft, IPO, GLOBE, WEBR, For Hire, Hindenburg, NYSE, Hepatitis B virus, Registration statement, China Biologic Products, HIV, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, Fraud, Cancer, News, Office of Inspector General, U.S. Department of Health and Human Services, Technology, Company, Science, Defendant, G-Technology, Lists of schools in England, Justice, Hindenburg Research, Complaint, LLC, SRI, Coronavirus, Private investigator, Renewable energy, Pharmaceutical industry, Security (finance), Enochian, P.C

On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.

Key Points: 
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, Enochians stock price fell $2.17 per share, or 36.97%, to close at $3.70 per share on May 25, 2022.
  • Additionally, Weber announced that Chris Scherzinger is departing from his roles as Chief Executive Officer and director of the Company.
  • For more information on the Weber class action go to: https://bespc.com/cases/WEBR
    About Bragar Eagel & Squire, P.C.